DiscoverMinding Memory
Minding Memory
Claim Ownership

Minding Memory

Author: Michigan Medicine Podcast Network

Subscribed: 17Played: 57
Share

Description

Welcome to Minding Memory. In this podcast we discuss topics related to dementia research. This is an all-hands-on-deck moment for dementia research, and we have topics for both those new to the space as well as old pros. We start with some basics, like: What exactly is dementia? What are the different types of dementia? What is the TICS, if not a swarm of blood-sucking insects?  But we also invite researchers on to discuss their interesting work to give you a glimpse at the questions, data, and methods moving the field forward. 

 

Minding Memory is co-hosted by Matthew Davis and Lauren Gerlach. Matt and Lauren are health services researchers and professors at the University of Michigan. Matt’s PhD is in Data Science and Lauren is a geriatric psychiatrist. The Minding Memory podcast is part of the Center to Accelerate Population Research in Alzheimer’s (CAPRA) at the University of Michigan, supported by the National Institute on Aging at the National Institutes of Health. Additional support also comes from the Institute for Healthcare Policy and Innovation. The content of this podcast does not represent the views of the National Institutes of Health or the University of Michigan. Please consider subscribing to this podcast and make sure to check out our website. On our website you’ll also find links to the center’s seminar series and data products created specifically for dementia research. 


You can subscribe to Minding Memory on Apple Podcasts, Spotify, or wherever you listen to podcasts.


Hosted on Acast. See acast.com/privacy for more information.

49 Episodes
Reverse
In this episode, Lauren & Matt talk to Brenda Roberts and Steven Barbieri from the National Council of Dementia Minds.The National Council of Dementia Minds is the first national not-for-profit organization founded and governed by people living with dementia. Its work focuses on education, advocacy, peer support, and changing public perception of what it means to live with dementia.Brenda and Steven talk about the National Council of Dementia Minds, the importance of peer support and education for people living with dementia. They focus on how better understanding the lived experiences of people living with dementia can help shape research, policy, and advocacy.The transcript for this episode can be found here.Links of InterestNational Council of Dementia MindsSteven A. Barbieri, Board President & FounderBrenda Roberts, Executive DirectorYou can listen on the Michigan Medicine podcasting network and other podcasting platforms such as Apple Podcasts and Spotify. This episode is also available on our CAPRA website. Hosted on Acast. See acast.com/privacy for more information.
In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice, and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations.Dr. Shireman discusses her recent study, “The Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents,” published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly reported antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnoses, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use.The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices, the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety with residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia.The transcript for this episode can be found here.Article Discussed in the Episode:Shireman TI, Coulibaly N, Zhang T, et al. Impact of federal antipsychotic use policy in nursing homes on new diagnoses for approved indications in dementia residents. J Am Geriatr Soc. 2024; 72(12): 3742-3752. doi:10.1111/jgs.19129You can listen on the Michigan Medicine podcasting network and other podcasting platforms such as Apple Podcasts and Spotify. This episode is also available on our CAPRA website. Hosted on Acast. See acast.com/privacy for more information.
In this episode, Lauren & Matt speak with Neguine Rezaii, MD, an Assistant Professor of Neurology at Harvard Medical School and a Board-Certified Neuropsychiatrist at Mass General Hospital. Dr. Rezaii’s research focuses on using natural language processing and artificial intelligence to improve the detection and classification of neurodegenerative disorders.Dr. Rezaii talks about her recent study, “Voiceprints of Cognitive Impairment: Analyzing Digital Voice for Early Detection of Alzheimer’s and Related Dementias,” which explores how artificial intelligence can analyze short speech samples to identify subtle signs of cognitive impairment. The study used speech recordings from 120 individuals and found that features such as pauses, word choice and the specificity of language can help distinguish cognitive impairment and Alzheimer’s disease.The conversation also explores how a simple 30-second speech test could potentially be used in clinical settings to support earlier detection and monitoring of cognitive impairment, as well as the challenges and ethical considerations that come with using AI to analyze something as personal as a person’s voice.The transcript for this episode can be found here.Article Discussed in the Episode:Rezaii, N., Wong, B., Aisen, P. et al. Voiceprints of cognitive impairment: analyzing digital voice for early detection of Alzheimer’s and related dementias. npj Dement. 1, 35 (2025). https://doi.org/10.1038/s44400-025-00040-0 DOI; npj Dementia volume 1, Article number: 35 (2025)You can listen on the Michigan Medicine podcasting network and other podcasting platforms such as Apple Podcasts and Spotify. This episode is also available on our CAPRA website. Hosted on Acast. See acast.com/privacy for more information.
In this episode, Lauren & Matt speak with Neil Mehta, PhD who is the associate dean for research and a professor in the Department of Epidemiology at the University of Texas Medical Branch in Galveston. Dr. Mehta’s research focuses on US life expectancy trends, the effects of obesity on disability and mortality, the sources of socioeconomic status disparities in mortality, and patterns of health in the United States and Europe.   Dr. Mehta talks about a recent manuscript from the NIA-funded TRENDS study called “Trends in Memory Function and Memory Impairment Among Older Adults in the United States and Europe, 1996 to 2018.”, which looks at data from several sources to compare trends in memory function across 13 different countries. The transcript for this episode can be found here. Neil Mehta, PhD Faculty Profile   Article Discussed in the Episode: Myrskylä M, Hale JM, Schneider DC, Mehta NK. Trends in Memory Function and Memory Impairment Among Older Adults in the United States and Europe, 1996-2018. J Gerontol A Biol Sci Med Sci. 2024 Nov 7;79(21 Suppl 11):S11-S21. doi: 10.1093/gerona/glae154. PMID: 38953519; PMCID: PMC11542220. You can listen on the Michigan Medicine podcasting network and other podcasting platforms such as Apple Podcasts and Spotify. This episode is also available on our CAPRA website.  Hosted on Acast. See acast.com/privacy for more information.
Welcome back to Season 6 of Minding Memory! In this episode, Lauren & Matt speak with Dr. Katherine (Kate) Possin, who holds the John Douglas French Alzheimer’s Foundation Professorship at the University of California, San Francisco Fein Memory & Aging Center.   Dr. Possin talks about the Care Ecosystem, a telephone and web-based model that provides ongoing education, support, care planning, and coordination for people living with dementia and their care partners. They’ll dig into how the Care Ecosystem was developed, and what studies have shown about its impact on people living with dementia.   The transcript for this episode can be found here.Katherine Possin, PhD Faculty ProfileThe Care Ecosystem at the UCSF Fein Memory & Aging Center  Article Discussed in the Episode:  Atkins KJ, Kahn JG, Possin KL. Cost-effectiveness and impact at Scale of Collaborative Care and Lecanemab for Alzheimer's Disease. Alzheimer's Dement. 2026; 2:e70054. https://doi.org/10.1002/bsa3.70054   You can subscribe to Minding Memory on Apple Podcasts, Spotify, or wherever you listen to podcasts. Hosted on Acast. See acast.com/privacy for more information.
loading
Comments